102 related articles for article (PubMed ID: 2826774)
1. Inhibition of climbing and mossy fiber input to mouse cerebellar Purkinje cells by cholecystokinin.
Wood PL; Steel DJ; Kim HS; Petrack B; Altar CA
J Pharmacol Exp Ther; 1988 Jan; 244(1):58-62. PubMed ID: 2826774
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologically induced changes in the 3':5'-cyclic guanosine monophosphate content of rat cerebellar cortex: difference between apomorphine, haloperidol and harmaline.
Biggio G; Costa E; Guidotti A
J Pharmacol Exp Ther; 1977 Jan; 200(1):207-15. PubMed ID: 13199
[TBL] [Abstract][Full Text] [Related]
3. Differential antagonism by proglumide of various CCK-mediated effects in mice.
Barbaz BS; Autry WL; Ambrose FG; Gerber R; Liebman JM
Prog Clin Biol Res; 1985; 192():151-8. PubMed ID: 4080708
[TBL] [Abstract][Full Text] [Related]
4. Effects of amylin on feeding of goldfish: interactions with CCK.
Thavanathan R; Volkoff H
Regul Pept; 2006 Jan; 133(1-3):90-6. PubMed ID: 16239037
[TBL] [Abstract][Full Text] [Related]
5. BMY-14802 antagonizes harmaline- and D-serine-induced increases in mouse cerebellar cyclic GMP: neurochemical evidence for a sigma receptor-mediated functional modulation of responses mediated by the N-methyl-D-aspartate receptor complex in vivo.
Rao TS; Cler JA; Emmett MR; Mick S; Iyengar S; Wood PL
Mol Pharmacol; 1990 Jun; 37(6):978-82. PubMed ID: 2163021
[TBL] [Abstract][Full Text] [Related]
6. Change in brain guanosine 3',5'-monophosphate (cGMP) content by thyrotropin-releasing hormone.
Mailman RB; Frye GD; Mueller RA; Breese GR
J Pharmacol Exp Ther; 1979 Feb; 208(2):169-75. PubMed ID: 33261
[TBL] [Abstract][Full Text] [Related]
7. CCK modulation of cerebellar afferents: dopaminergic involvement.
Wood PL
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(3-4):513-8. PubMed ID: 2546180
[TBL] [Abstract][Full Text] [Related]
8. Cerebellar cyclic GMP in p,p'-DDT myoclonus: effects of antimyoclonic agents.
Chung E
Res Commun Chem Pathol Pharmacol; 1983 Apr; 40(1):87-98. PubMed ID: 6306746
[TBL] [Abstract][Full Text] [Related]
9. The effect of cholecystokinin peptides on ovine duodeno-jejunal slow waves with and without pretreatment with proglumide.
Romański KW
J S Afr Vet Assoc; 2007 Dec; 78(4):209-14. PubMed ID: 18507220
[TBL] [Abstract][Full Text] [Related]
10. Vagally mediated, nonparacrine effects of cholecystokinin-8s on rat pancreatic exocrine secretion.
Viard E; Zheng Z; Wan S; Travagli RA
Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G493-500. PubMed ID: 17569741
[TBL] [Abstract][Full Text] [Related]
11. Correlations between cerebellar cyclic GMP and motor effects induced by deltamethrin: independence of olivo-cerebellar tract.
Brodie ME
Neurotoxicology; 1983; 4(4):1-11. PubMed ID: 6322058
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms by which diazepam, muscimol, and other drugs change the content of cGMP in cerebellar cortex.
Biggio G; Brodie BB; Costa E; Guidotti A
Proc Natl Acad Sci U S A; 1977 Aug; 74(8):3592-6. PubMed ID: 198792
[TBL] [Abstract][Full Text] [Related]
13. SNF9007: a novel analgesic that acts simultaneously at delta 1, delta 2 and mu opioid receptors.
Williams CL; Rosenfeld GC; Dafny N; Fang SN; Hruby VJ; Bowden G; Cullinan CA; Burks TF
J Pharmacol Exp Ther; 1994 May; 269(2):750-5. PubMed ID: 8182541
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization of cGMP regulation by the biarylpropylsulfonamide class of positive, allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
Ryder JW; Falcone JF; Manro JR; Svensson KA; Merchant KM
J Pharmacol Exp Ther; 2006 Oct; 319(1):293-8. PubMed ID: 16803862
[TBL] [Abstract][Full Text] [Related]
15. Cholecystokinin-8s excites identified rat pancreatic-projecting vagal motoneurons.
Wan S; Coleman FH; Travagli RA
Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G484-92. PubMed ID: 17569742
[TBL] [Abstract][Full Text] [Related]
16. Cerebellar output regulation by the climbing and mossy fibers with and without the inferior olive.
Bardin JM; Batini C; Billard JM; Buisseret-Delmas C; Conrath-Verrier M; Corvaja N
J Comp Neurol; 1983 Feb; 213(4):464-77. PubMed ID: 6300201
[TBL] [Abstract][Full Text] [Related]
17. Long-lasting inhibitory action of caerulein on climbing fiber system in the cerebellum of the rat.
Kageyama H; Kurosawa A
Neuropharmacology; 1989 Sep; 28(9):991-5. PubMed ID: 2554189
[TBL] [Abstract][Full Text] [Related]
18. Activation of central nervous system cholecystokinin receptors stimulates respiration in the cat.
Gillis RA; Quest JA; Pagani FD; Souza JD; Da Silva AM; Jensen RT; Garvey TQ; Hamosh P
J Pharmacol Exp Ther; 1983 Feb; 224(2):408-14. PubMed ID: 6296361
[TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin and an evoked response in the dentate gyrus.
Sinton CM
Neuropeptides; 1988 Jul; 12(1):29-34. PubMed ID: 3419558
[TBL] [Abstract][Full Text] [Related]
20. On the mechanism of the decrease in cerebellar cyclic GMP content elicited by opiate receptor agonists.
Biggio G; Guidotti A; Costa E
Naunyn Schmiedebergs Arch Pharmacol; 1977 Jan; 296(2):117-21. PubMed ID: 189228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
